<?xml-stylesheet type='text/xsl' href='anzctrTransform.xsl'?>
<ANZCTR_Trial requestNumber="83241">
  <stage>Registered</stage>
  <submitdate>7/10/2008</submitdate>
  <approvaldate>17/06/2009</approvaldate>
  <actrnumber>ACTRN12609000473268</actrnumber>
  <trial_identification>
    <studytitle>Effect of muscular stretching following transcutaneous electrical nerve stimulation (TENS) versus usual muscular stretching only on flexibility and pain in healthy people</studytitle>
    <scientifictitle>Effects of muscular stretching and transcutaneous electrical nerve stimulation compared to usual muscular stretching on flexibility of hamstring and pain for healthy people: a randomized controlled trial</scientifictitle>
    <utrn />
    <trialacronym />
  </trial_identification>
  <conditions>
    <healthcondition>stretching and TENS on flexibility of hamstring muscles in healthy women, without musculoskeletal disease.</healthcondition>
    <conditioncode>
      <conditioncode1>Musculoskeletal</conditioncode1>
      <conditioncode2>Normal musculoskeletal and cartilage development and function</conditioncode2>
    </conditioncode>
  </conditions>
  <interventions>
    <interventions>Group 1, Stretching: static hamstring stretches (3 repetitions of 30 seconds) daily for 2 weeks. Group 2, Stretching + TENS: 10 minutes TENS (100Hz, 40 micros), immediately followed by static hamstring stretches (3 repetitions of 30 seconds) daily for 2 weeks. The TENS was connected to the participant by self-adhesive electrodes. During the Stretching the TENS remains switched on.</interventions>
    <comparator>Group 3, Control: no treatment given for a period of 2 weeks.</comparator>
    <control>Active</control>
    <interventioncode>Rehabilitation</interventioncode>
  </interventions>
  <outcomes>
    <primaryOutcome>
      <outcome>range of motion using a digital goniometer</outcome>
      <timepoint>baseline and at 4 weeks after commencement of treatment.</timepoint>
    </primaryOutcome>
    <secondaryOutcome>
      <outcome>pain using the visual analogic scale (VAS)</outcome>
      <timepoint>baseline and at 4 weeks after commencement of treatment.</timepoint>
    </secondaryOutcome>
  </outcomes>
  <eligibility>
    <inclusivecriteria>healthy people, without musculoskeletal disease.</inclusivecriteria>
    <inclusiveminage>18</inclusiveminage>
    <inclusiveminagetype>Years</inclusiveminagetype>
    <inclusivemaxage>25</inclusivemaxage>
    <inclusivemaxagetype>Years</inclusivemaxagetype>
    <inclusivegender>Females</inclusivegender>
    <healthyvolunteer>Yes</healthyvolunteer>
    <exclusivecriteria>Subjects will be excluded from the study if they are unable to tolerate the stretching.</exclusivecriteria>
  </eligibility>
  <trial_design>
    <studytype>Interventional</studytype>
    <purpose>Treatment</purpose>
    <allocation>Randomised controlled trial</allocation>
    <concealment>the subjects were allocated by sealed opaque envelopes</concealment>
    <sequence>subjects were randomly assigned to 3 groups. One control group and two stretching groups (stretching  and stretching + TENS). we select the pateints randomly by using randomisation tablesite. we used a simple randomisation by using a randomisation table created by a computer software.</sequence>
    <masking>Blinded (masking used)</masking>
    <assignment>Parallel</assignment>
    <designfeatures>no other design features.</designfeatures>
    <endpoint>Efficacy</endpoint>
    <statisticalmethods />
    <masking1 />
    <masking2 />
    <masking3 />
    <masking4 />
    <patientregistry />
    <followup />
    <followuptype />
    <purposeobs />
    <duration />
    <selection />
    <timing />
  </trial_design>
  <recruitment>
    <phase>Not Applicable</phase>
    <anticipatedstartdate>1/10/2008</anticipatedstartdate>
    <actualstartdate />
    <anticipatedenddate />
    <actualenddate />
    <samplesize>30</samplesize>
    <actualsamplesize />
    <recruitmentstatus>Closed: follow-up complete</recruitmentstatus>
    <recruitmentcountry />
    <recruitmentstate />
    <countryoutsideaustralia>
      <country>Brazil</country>
      <state>rio grande do norte</state>
    </countryoutsideaustralia>
  </recruitment>
  <sponsorship>
    <primarysponsortype>University</primarysponsortype>
    <primarysponsorname>departamento de fisioterapia</primarysponsorname>
    <primarysponsoraddress>universidade federal do rio grande do norte, avenida salgado filho (br 101), lagoa nova, natal-rn-brasil, CEP 59078970</primarysponsoraddress>
    <primarysponsorcountry>Brazil</primarysponsorcountry>
    <fundingsource>
      <fundingtype>University</fundingtype>
      <fundingname>universidade federal do rio grande do norte</fundingname>
      <fundingaddress>avenida salgado filho (br 101), lagoa nova, campus central, natal-rn-brasil, CEP 59078970</fundingaddress>
      <fundingcountry>Brazil</fundingcountry>
    </fundingsource>
    <secondarysponsor>
      <sponsortype>Individual</sponsortype>
      <sponsorname>ricardo oliveira guerra</sponsorname>
      <sponsoraddress>avenida salgado filho (br 101), lagoa nova, CEP 59078970</sponsoraddress>
      <sponsorcountry>Brazil</sponsorcountry>
    </secondarysponsor>
  </sponsorship>
  <ethicsAndSummary>
    <summary>The increase of the stretching pain tolerance is an important factor for flexibility gain. Transcutaneous Electrical Nerve Stimulation (TENS)  is an important therapy for pain treatment, however its use during stretching was not investigated. To evaluate stretching and TENS association effect in hamstrings muscles of healthy women about flexibility gain</summary>
    <trialwebsite />
    <publication />
    <ethicsreview>Approved</ethicsreview>
    <publicnotes />
    <ethicscommitee>
      <ethicname>hospital universitario onofre lopes</ethicname>
      <ethicaddress>universidade federal do rio grande do norte, avenida salgado filho (br 101), lagoa nova, natal-rn-brasil, CEP 59078970</ethicaddress>
      <ethicapprovaldate>1/08/2007</ethicapprovaldate>
      <hrec>1/06/0037</hrec>
      <ethicsubmitdate>1/07/2007</ethicsubmitdate>
      <ethiccountry>Brazil</ethiccountry>
    </ethicscommitee>
  </ethicsAndSummary>
  <attachment />
  <contacts>
    <contact>
      <title />
      <name>alvaro campos cavalcanti maciel</name>
      <address>rua moises gosson, 1442, Natal-RN. CEP: 59056-060</address>
      <phone>+55 84 91296796</phone>
      <fax />
      <email>alvarohuab@ufrnet.br</email>
      <country>Brazil</country>
      <type>Scientific Queries</type>
    </contact>
    <contact>
      <title />
      <name>alvaro campos cavalcanti maciel</name>
      <address>rua moises gosson, 1442, natal-rn. CEP: 59056-060</address>
      <phone>+55 84 91296796</phone>
      <fax />
      <email>alvarohuab@ufrnet.br</email>
      <country>Brazil</country>
      <type>Public Queries</type>
    </contact>
    <contact>
      <title />
      <name>alvaro campos cavalcanti maciel</name>
      <address>rua moises gosson, 1442, Natal-RN. CEP: 59056-060.</address>
      <phone>+55 84 91296796</phone>
      <fax />
      <email>alvarohuab@ufrnet.br</email>
      <country>Brazil</country>
      <type>Updating Information</type>
    </contact>
    <contact>
      <title />
      <name />
      <address />
      <phone />
      <fax />
      <email />
      <country />
      <type>Principal Investigator</type>
    </contact>
  </contacts>
</ANZCTR_Trial>